Q2 2026 · Form 13F LedgerData source: SEC EDGAR  
H

HOLDER.TOP

Who owns what — the quarterly ledger of U.S. institutional holdings.
EN · 简 · 繁
Funds / Remedium Capital Partners, LLC
Form 13F · Q2 2026

Remedium Capital Partners, LLC

CIK 2104501Filed 2026-08-0713F-HR View the filing on EDGAR ↗
$452M
Reported book value
6
Positions
3
Quarters on record
Top 50
Positions

Remedium Capital Partners, LLC — holdings

Top 6 positions of 6, ranked by reported value. Share change is versus the previous quarter.
#SecuritySharesShare Δ QoQValue% of book
1ORKA Oruka Therapeutics Inc1.6M+0.0%$149M33.0%
2SYRE Spyre Therapeutics Inc1.5M+0.5%$130M28.8%
3APOGEE THERAPEUTICS INC Apogee Therapeutics Inc586,691+0.5%$78M17.2%
4DMRA Damora Therapeutics Inc2.0M+0.0%$53M11.8%
5JBIO Jade Biosciences Inc1.6M+0.0%$35M7.8%
6CBIO Crescent Biopharma Inc.361,250—$7M1.4%
Source: Form 13F filings via SEC EDGAR. Positions as of Jun 30, 2026. Options (put/call) are excluded from share counts.